2021
DOI: 10.3399/bjgp21x717329
|View full text |Cite
|
Sign up to set email alerts
|

The tapestry of reflux syndromes: translating new insight into clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…A key contributor to PPI overutilization, especially high-dose and long-term use, is prescription for reflux-like symptoms (e.g., heartburn, regurgitation) or non-specific symptoms, leading to a presumptive diagnosis of “refractory” GORD. Despite growing awareness of “Disorders of Gut-Brain Interaction” and recognition of altered perception as a major determinant of reflux-like symptoms (reflux hypersensitivity and functional heartburn), PPIs remain a pragmatic first-line approach for patients presenting with reflux-like symptoms [ 27 ]. Dyspepsia and GORD clinical guidelines recommend 4–8 weeks of PPI treatment for resolution of GORD symptoms, after which PPIs should be discontinued [ 28 , 29 ].…”
Section: Key Drivers Of Ppi Overutilizationmentioning
confidence: 99%
“…A key contributor to PPI overutilization, especially high-dose and long-term use, is prescription for reflux-like symptoms (e.g., heartburn, regurgitation) or non-specific symptoms, leading to a presumptive diagnosis of “refractory” GORD. Despite growing awareness of “Disorders of Gut-Brain Interaction” and recognition of altered perception as a major determinant of reflux-like symptoms (reflux hypersensitivity and functional heartburn), PPIs remain a pragmatic first-line approach for patients presenting with reflux-like symptoms [ 27 ]. Dyspepsia and GORD clinical guidelines recommend 4–8 weeks of PPI treatment for resolution of GORD symptoms, after which PPIs should be discontinued [ 28 , 29 ].…”
Section: Key Drivers Of Ppi Overutilizationmentioning
confidence: 99%
“…29 Manifestations related to acid reflux are more common in older patients (more than 45 years of age), those with central obesity, hiatus hernia and known lifestyle and dietary risk factors, such as high-fat diet and irregular eating habits. 29 On the other hand, functional symptoms are more common in younger patients and women, and frequently co-present with symptoms suggestive of gut-brain interaction disorder (postprandial fullness, nausea, early satiation, epigastric burning, IBS), [31][32][33] somatisation (e.g. fibromyalgia, headache, back pain, chronic fatigue, dizziness), 8,34,35 and anxiety.…”
Section: Patient-clinician Communicationmentioning
confidence: 99%
“…A comprehensive clinical history will help determine whether the predominant cause of reflux‐like symptoms is likely to be altered perception or altered physiology, an essential distinction to optimise individualised management (Figure 3). 29 Manifestations related to acid reflux are more common in older patients (more than 45 years of age), those with central obesity, hiatus hernia and known lifestyle and dietary risk factors, such as high‐fat diet and irregular eating habits 29 . On the other hand, functional symptoms are more common in younger patients and women, 30,31 and frequently co‐present with symptoms suggestive of gut‐brain interaction disorder (postprandial fullness, nausea, early satiation, epigastric burning, IBS), 31–33 somatisation (e.g.…”
Section: Personalised Managementmentioning
confidence: 99%
“…FH patients do not respond to PPI therapy and, therefore, they should be treated with medications that can reduce visceral hypersensitivity and improve co-existing psychological dysfunction [ 23 ▪ ].…”
Section: Functional Heartburn Differs From Nonerosive Reflux Disease/...mentioning
confidence: 99%